Evidence map›Paper›PMID 24782527›Full record

ArticleNucleic acids research2014

GeneGenie: optimized oligomer design for directed evolution.

Neil Swainston, Andrew Currin, Philip J Day, Douglas B Kell

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 39 citations in OpenAlex.

  1. Review
  2. Article
  3. Engineering ofMetabolic engineering communications · 2022
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Engineering the YeastFrontiers in bioengineering and biotechnology · 2019
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Neil SwainstonManchester Institute of Biotechnology, The University of Manchester, Manchester M1 7DN, UK School of Computer Science, The University of Manchester, Manchester M13 9PL, UK neil.swainston@manchester.ac.uk.
Andrew CurrinManchester Institute of Biotechnology, The University of Manchester, Manchester M1 7DN, UK School of Chemistry, The University of Manchester, Manchester M13 9PL, UK.
Philip J DayManchester Institute of Biotechnology, The University of Manchester, Manchester M1 7DN, UK Faculty of Medical and Human Sciences, The University of Manchester, Manchester M13 9PT, UK.
Douglas B KellManchester Institute of Biotechnology, The University of Manchester, Manchester M1 7DN, UK School of Chemistry, The University of Manchester, Manchester M13 9PL, UK.
University of Manchester · GB

Funding

Biotechnology and Biological Sciences Research Council
6 · The paper itself

Abstract

GeneGenie, a new online tool available at http://www.gene-genie.org, is introduced to support the design and self-assembly of synthetic genes and constructs. GeneGenie allows for the design of oligonucleotide cohorts encoding the gene sequence optimized for expression in any suitable host through an intuitive, easy-to-use web interface. The tool ensures consistent oligomer overlapping melting temperatures, minimizes the likelihood of misannealing, optimizes codon usage for expression in a selected host, allows for specification of forward and reverse cloning sequences (for downstream ligation) and also provides support for mutagenesis or directed evolution studies. Directed evolution studies are enabled through the construction of variant libraries via the optional specification of 'variant codons', containing mixtures of bases, at any position. For example, specifying the variant codon TNT (where N is any nucleotide) will generate an equimolar mixture of the codons TAT, TCT, TGT and TTT at that position, encoding a mixture of the amino acids Tyr, Ser, Cys and Phe. This facility is demonstrated through the use of GeneGenie to develop and synthesize a library of enhanced green fluorescent protein variants.

Indexed as

Genes, SyntheticSoftwareAlgorithmsCodonDirected Molecular EvolutionGreen Fluorescent ProteinsInternetOligonucleotidesSequence Analysis, ProteinCodonenhanced green fluorescent proteinGreen Fluorescent ProteinsOligonucleotides

Identifiers

PMID24782527
PMCPMC4086129
OpenAlexW2157294669

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.